OCGN CIK: 1372299

Ocugen, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY23
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
73.5
FY23:
56.6
FY23:
43.0
FY24:
61.7
FY25:
24.3
(positive)
Change from FY23 to FY25
millions USD
FY23:
15.5
FY23:
18.1
FY23:
21.6
FY24:
20.8
FY25:
19.2
Total assets
Change from FY23 to FY25
millions USD
FY23:
89.0
FY23:
74.7
FY23:
64.5
FY24:
82.4
FY25:
43.5

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
24.5
FY23:
19.7
FY23:
17.1
FY24:
21.6
FY25:
23.0
(negative)
Change from FY23 to FY25
millions USD
FY23:
5.24
FY23:
5.16
FY23:
6.89
FY24:
31.2
FY25:
32.6
(positive)
Change from FY23 to FY25
millions USD
FY23:
59.2
FY23:
49.8
FY23:
40.6
FY24:
29.6
FY25:
−12.2
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
89.0
FY23:
74.7
FY23:
64.5
FY24:
82.4
FY25:
43.5

All amounts in millions USD Data source:SEC EDGAR